China IP Law Admin CNIPA Rules on Patent Linkage Cases : vim

China National Intellectual Property Administration CNIPA concluded first batch of patent linkage cases related to Oxycodone Hydrochloride Sustained-Release Tablets from Purdue Pharmaceuticals. China’s patent linkage system prevents marketing authorization for generics.

Related Keywords

Beijing , China , Chinese , , Ip Court , Purdue Pharmaceuticals , China National Intellectual Property Administration , Hydrochloride Sustained Release , Legal , Business , World , Intellectual Property , P Law , Nipa , Patent Linkage , Patents , Xycodone Hydrochloride Sustained Release Tablets ,